Instituto de Farmacia Industrial, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal sn 28040, Spain.
J Microencapsul. 2011;28(8):791-8. doi: 10.3109/02652048.2011.621554. Epub 2011 Oct 3.
The effects of viscosity and hydrophilic characteristics of different PLGA polymers on the microencapsulation of insulin have been studied in vitro and in vivo after subcutaneous administration to hyperglycemic rats. Hydrophilic PLGA polymers produced a higher burst effect than the hydrophobic ones. Moreover, an incomplete insulin release was observed with the hydrophilic PLGA polymers in comparison with the hydrophobic ones. An explanation for that incomplete release can be the development of polymer-insulin interactions associated to the polymer hydrophilic/hydrophobic character, as detected by DSC analysis. Differences in the release rate of microsphere formulations lead to differences in the hypoglycemic action and the weight of animals. Hydrophobic PLGA was able to prolong the hypoglycemic action up to 4 weeks which is at least double than that obtained with hydrophilic PLGA of a similar viscosity. Comparing insulin microspheres with an immediate release formulation, microspheres can increase insulin relative bioavailability up to four times.
已研究不同 PLGA 聚合物的粘度和亲水性对胰岛素的微囊化作用,包括在体外和经皮下给予高血糖大鼠后的体内情况。亲水性 PLGA 聚合物比疏水性 PLGA 聚合物产生更高的突释效应。此外,与疏水性 PLGA 聚合物相比,亲水性 PLGA 聚合物观察到不完全的胰岛素释放。通过 DSC 分析可以解释这种不完全释放是由于与聚合物亲水性/疏水性特征相关的聚合物-胰岛素相互作用的发展。微球制剂释放率的差异导致动物的降血糖作用和体重的差异。疏水性 PLGA 能够将降血糖作用延长至 4 周,至少是具有相似粘度的亲水性 PLGA 的两倍。与即刻释放制剂相比,胰岛素微球可以将胰岛素的相对生物利用度提高至四倍。